The Impact of clinical pharmacy services within an oncology Center of excellence on patient outcomes and cost efficiency.

Authors

Lane Beckes, Elias Assaf, Ryan McDade, Kali Sassack, Megan Winebrenner

Published in

Expert review of pharmacoeconomics & outcomes research. Aug 11, 2026. Epub Aug 11, 2026.

Abstract

Evidence is mounting that clinical programs for specialty pharmacies can substantively contribute to improved treatment. As cancer is currently the second leading cause of death in the United States, clinical pharmacy programs may improve outcomes for millions of cancer patients. A center of excellence in outpatient specialty pharmacies may best leverage these benefits.
We observed the relationship between engaging with an insurance provider's affiliated pharmacy's remotely operated Oncology Center of Excellence (COE) and health outcomes and medical costs for Medicare Part-D beneficiaries. We then tested whether engagement with COE engagement mediated outcomes during a 12-month period.
Both propensity score matching and regression models indicated lower hospitalizations, emergency department (ED) visits, and medical costs for those who primarily used the affiliated pharmacy. Follow up mediation analyses indicated these effects were mediated by engagement with the COE.
Engagement with this COE was associated with lower medical costs and fewer ED visits and hospitalizations. The high-quality clinical pharmacy programs and services associated with COE's likely contributed to better and less expensive oncology care overall.

PMID:
42581491
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.